CBIO Market Cap & Key Metrics
Crescent Biopharma, Inc.
$13.18
-$0.31(-2.30%)
34
Overall
40
Value
36
Tech
28
Quality
Market Cap
$501.07M
Volume
13.81K
52W Range
$8.72 - $27.41
Target Price
$31.33
CBIO market cap is $501.07M. This page lists Crescent Biopharma, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
CBIO Key Metrics
- Market cap
- $501.07M
- EPS estimate, current year
- $-2.93
- EPS growth, 3-year
- +0.00%
- Value score
- 40
- Quality score
- 28
- Technical score
- 36
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $10.84M | - | $10.0K | $75.0K | $1.16M |
| EBITDA | -$149.46M | -$17.02M | -$35.89M | -$47.20M | -$63.18M |
| EPS | - | $-59.00 | $-58.00 | $-89.00 | $-123.00 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CBIO | $13.18 | -2.3% | 13.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Crescent Biopharma, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW